Vestmark Advisory Solutions’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
PCM
AAM
WCMNY
PWAM
Vestmark Advisory Solutions's AMED Position: Q3 2023 in Review
Vestmark Advisory Solutions sold out of Amedisys (AMED) in Q3 2023, closing a stake of 5,372 shares — an estimated $491K sold.
Vestmark Advisory Solutions first reported a position in AMED in Q2 2019 and held it in 16 quarters. The position peaked at $1.15M in Q2 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.
- Vestmark Advisory Solutions reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
- Vestmark Advisory Solutions sold 5,372 Amedisys shares in Q3 2023, an estimated $491K.
- Vestmark Advisory Solutions first reported a position in Amedisys in Q2 2019 and held it in 16 quarters.
- Vestmark Advisory Solutions's Amedisys position peaked at $1.15M in Q2 2021.
- 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.
Based on Vestmark Advisory Solutions's 13F filing for Q3 2023, filed 6 Nov 2023.